{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:13:01Z","timestamp":1782861181750,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Progranulin is a secreted growth factor associated with multiple physiological functions in ischemic pathophysiology. However, it is still not fully understood how progranulin is involved in ischemic lesion and cardiac remodeling after myocardial infarction (MI). In this study, we investigated the effects of progranulin on myocardial ischemia and reperfusion injury. We investigated progranulin expression using Western blotting and immunostaining after permanent left coronary artery (LCA) occlusion in mice. Infarct size and the number of infiltrating neutrophils were measured 24\u00a0h after permanent LCA occlusion. Recombinant mouse progranulin was administered before LCA occlusion. In addition, we evaluated cardiac function using cardiac catheterization and echocardiography, and fibrosis size by Masson\u2019s trichrome staining after myocardial ischemia\/reperfusion in rabbits. Recombinant human progranulin was administered immediately after induction of reperfusion. Progranulin expression increased in the myocardial ischemic area 1, 3, and 5\u00a0days after permanent LCA occlusion in mice. The administration of recombinant mouse progranulin significantly attenuated infarct size and infiltrating neutrophils 24\u00a0h after permanent LCA occlusion in mice. We also found that administration of recombinant human progranulin ameliorated the deterioration of cardiac dysfunction and fibrosis after myocardial ischemia\/reperfusion in rabbits. These findings suggest that progranulin may protect myocardial ischemia\/reperfusion injury.<\/jats:p>","DOI":"10.1038\/s41598-020-68804-7","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T10:04:22Z","timestamp":1594893862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effects of progranulin on the pathological conditions in experimental myocardial infarction model"],"prefix":"10.1038","volume":"10","author":[{"given":"Takahiro","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anri","family":"Nishinaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genjiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Minatoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"68804_CR1","doi-asserted-by":"crossref","first-page":"H1439","DOI":"10.1152\/ajpheart.00139.2019","volume":"316","author":"G Heusch","year":"2019","unstructured":"Heusch, G. Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what?. Am. J. Physiol. Hear. Circ. Physiol. 316, H1439\u2013H1446 (2019).","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"68804_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ije\/dyq165","volume":"40","author":"S Mendis","year":"2011","unstructured":"Mendis, S. et al. World Health Organization definition of myocardial infarction: 2008\u201309 revision. Int. J. Epidemiol. 40, 139\u2013146 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"68804_CR3","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/circ.131.suppl_2.o29","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian, D. et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131, e29\u2013e39 (2015).","journal-title":"Circulation"},{"key":"68804_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Eur. Heart J. 40, 237\u2013269 (2019).","journal-title":"Eur. Heart J."},{"key":"68804_CR5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bmj.b1807","volume":"338","author":"SS Rathore","year":"2009","unstructured":"Rathore, S. S. et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ 338, 1312\u20131315 (2009).","journal-title":"BMJ"},{"key":"68804_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy, D. J. & Yellon, D. M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92\u2013100 (2013).","journal-title":"J. Clin. Invest."},{"key":"68804_CR7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMra065985","volume":"357","author":"BK Nallamothu","year":"2007","unstructured":"Nallamothu, B. K., Bradley, E. H. & Krumholz, H. M. Time to treatment in primary percutaneous coronary intervention. N. Engl. J. Med. 357, 1631\u20131638 (2007).","journal-title":"N. Engl. J. Med."},{"key":"68804_CR8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","volume":"115","author":"DJ Hausenloy","year":"2019","unstructured":"Hausenloy, D. J. et al. The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection. Cardiovasc. Res. 115, 1143\u20131155 (2019).","journal-title":"Cardiovasc. Res."},{"key":"68804_CR9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/qshc.2006.019331","volume":"16","author":"KM Jacobson","year":"2007","unstructured":"Jacobson, K. M., Long, K. H., McMurtry, E. K., Naessens, J. M. & Rihal, C. S. The economic burden of complications during percutaneous coronary intervention. Qual. Saf. Heal. Care 16, 154\u2013159 (2007).","journal-title":"Qual. Saf. Heal. Care"},{"key":"68804_CR10","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","volume":"65","author":"B Ib\u00e1\u00f1ez","year":"2015","unstructured":"Ib\u00e1\u00f1ez, B., Heusch, G., Ovize, M. & Van De Werf, F. Evolving therapies for myocardial ischemia\/reperfusion injury. J. Am. Coll. Cardiol. 65, 1454\u20131471 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68804_CR11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/dvdy.10341","volume":"227","author":"R Daniel","year":"2003","unstructured":"Daniel, R., Daniels, E., He, Z. & Bateman, A. Progranulin (acrogranin\/PC cell-derived growth factor\/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev. Dyn. 227, 593\u2013599 (2003).","journal-title":"Dev. Dyn."},{"key":"68804_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm816","volume":"9","author":"Z He","year":"2003","unstructured":"He, Z., Ong, C. H. P., Halper, J. & Bateman, A. Progranulin is a mediator of the wound response. Nat. Med. 9, 225\u2013229 (2003).","journal-title":"Nat. Med."},{"key":"68804_CR13","first-page":"2438","volume":"118","author":"K Kessenbrock","year":"2008","unstructured":"Kessenbrock, K. et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J. Clin. Invest. 118, 2438\u20132447 (2008).","journal-title":"J. Clin. Invest."},{"key":"68804_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20091568","volume":"207","author":"F Yin","year":"2010","unstructured":"Yin, F. et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med. 207, 117\u2013128 (2010).","journal-title":"J. Exp. Med."},{"key":"68804_CR15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2741\/4234","volume":"19","author":"J Konopka","year":"2014","unstructured":"Konopka, J., Richbourgh, B. & Liu, C. The role of PGRN in musculoskeletal development and disease. Front. Biosci. Landmark 19, 662\u2013671 (2014).","journal-title":"Front. Biosci. Landmark"},{"key":"68804_CR16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/002215540004800713","volume":"48","author":"R Daniel","year":"2000","unstructured":"Daniel, R., He, Z., Carmichael, K. P., Halper, J. & Bateman, A. Cellular localization of gene expression for progranulin. J. Histochem. Cytochem. 48, 999\u20131009 (2000).","journal-title":"J. Histochem. Cytochem."},{"key":"68804_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"M Hosokawa","year":"2017","unstructured":"Hosokawa, M. et al. Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation. Sci. Rep. 7, 1\u201311 (2017).","journal-title":"Sci. Rep."},{"key":"68804_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.12659\/MSMBR.916258","volume":"25","author":"AM Alyahya","year":"2019","unstructured":"Alyahya, A. M. et al. The effects of progranulin in a rat model of acute myocardial ischemia\/reperfusion are mediated by activation of the P13K\/Akt signaling pathway. Med. Sci. Monit. Basic Res. 25, 229\u2013237 (2019).","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"68804_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-10-105","volume":"10","author":"Y Egashira","year":"2013","unstructured":"Egashira, Y. et al. The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J. Neuroinflam. 10, 2\u201313 (2013).","journal-title":"J. Neuroinflam."},{"key":"68804_CR20","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ki.2014.403","volume":"87","author":"M Zhou","year":"2015","unstructured":"Zhou, M. et al. Progranulin protects against renal ischemia\/reperfusion injury in mice. Kidney Int. 87, 918\u2013929 (2015).","journal-title":"Kidney Int."},{"key":"68804_CR21","first-page":"969","volume":"26","author":"Y Tanaka","year":"2017","unstructured":"Tanaka, Y. et al. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes. Hum. Mol. Genet. 26, 969\u2013988 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"68804_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vascn.2012.05.009","volume":"66","author":"RD Sarazan","year":"2012","unstructured":"Sarazan, R. D., Kroehle, J. P. & Main, B. W. Left ventricular pressure, contractility and dP\/dtmaxin nonclinical drug safety assessment studies. J. Pharmacol. Toxicol. Methods 66, 71\u201378 (2012).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"68804_CR23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"365","author":"V Talman","year":"2016","unstructured":"Talman, V. & Ruskoaho, H. Cardiac fibrosis in myocardial infarction\u2014from repair and remodeling to regeneration. Cell Tissue Res. 365, 563\u2013581 (2016).","journal-title":"Cell Tissue Res."},{"key":"68804_CR24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","volume":"7","author":"SWM Van Den Borne","year":"2010","unstructured":"Van Den Borne, S. W. M. et al. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7, 30\u201337 (2010).","journal-title":"Nat. Rev. Cardiol."},{"key":"68804_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"S Luo","year":"2017","unstructured":"Luo, S. et al. ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1\/2-dependent ROCK1 activation. Sci. Rep. 7, 1\u201314 (2017).","journal-title":"Sci. Rep."},{"key":"68804_CR26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jcmm.12756","volume":"20","author":"Y Yu","year":"2016","unstructured":"Yu, Y. et al. Progranulin deficiency leads to severe inflammation, lung injury and cell death in a mouse model of endotoxic shock. J. Cell. Mol. Med. 20, 506\u2013517 (2016).","journal-title":"J. Cell. Mol. Med."},{"key":"68804_CR27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.yjmcc.2009.07.015","volume":"48","author":"M Dobaczewski","year":"2010","unstructured":"Dobaczewski, M., Gonzalez-Quesada, C. & Frangogiannis, N. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J. Mol. Cell Cardiol. 48, 504\u2013511 (2010).","journal-title":"J. Mol. Cell Cardiol."},{"key":"68804_CR28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","volume":"94","author":"M Nian","year":"2004","unstructured":"Nian, M., Lee, P., Khaper, N. & Liu, P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 94, 1543\u20131553 (2004).","journal-title":"Circ. Res."},{"key":"68804_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0008-6363(02)00413-3","volume":"55","author":"A Deten","year":"2002","unstructured":"Deten, A., Volz, H. C., Driest, W. & Zimmer, H. G. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc. Res. 55, 329\u2013340 (2002).","journal-title":"Cardiovasc. Res."},{"key":"68804_CR30","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/brain\/awv079","volume":"138","author":"M Kanazawa","year":"2015","unstructured":"Kanazawa, M. et al. Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke. Brain 138, 1932\u20131948 (2015).","journal-title":"Brain"},{"key":"68804_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2019.00001","volume":"6","author":"SL Puhl","year":"2019","unstructured":"Puhl, S. L. & Steffens, S. Neutrophils in post-myocardial infarction inflammation: damage vs. resolution?. Front. Cardiovasc. Med. 6, 1\u20139 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"68804_CR32","first-page":"187","volume":"38","author":"M Horckmans","year":"2017","unstructured":"Horckmans, M. et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur. Heart J. 38, 187\u2013197 (2017).","journal-title":"Eur. Heart J."},{"key":"68804_CR33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.15252\/emmm.201506083","volume":"8","author":"MJ Schloss","year":"2016","unstructured":"Schloss, M. J. et al. The time-of-day of myocardial infarction onset affects healing through oscillations in cardiac neutrophil recruitment. EMBO Mol. Med. 8, 937\u2013948 (2016).","journal-title":"EMBO Mol. Med."},{"key":"68804_CR34","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1253\/circj.CJ-16-0949","volume":"81","author":"K Fujisue","year":"2017","unstructured":"Fujisue, K. et al. Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction. Circ. J. 81, 1174\u20131182 (2017).","journal-title":"Circ. J."},{"key":"68804_CR35","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","volume":"105","author":"J D\u00edez","year":"2002","unstructured":"D\u00edez, J. et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105, 2512\u20132517 (2002).","journal-title":"Circulation"},{"key":"68804_CR36","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein, S. et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human: Heart structural deterioration and compensatory mechanisms. Circulation 107, 984\u2013991 (2003).","journal-title":"Circulation"},{"key":"68804_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1155\/2011\/126240","volume":"31","author":"Y Yilmaz","year":"2011","unstructured":"Yilmaz, Y. et al. Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dis. Markers 31, 205\u2013210 (2011).","journal-title":"Dis. Markers"},{"key":"68804_CR38","doi-asserted-by":"crossref","unstructured":"Yoo, W. et al. Progranulin attenuates liver fibrosis by downregulating the inflammatory response. Cell Death Dis. 10 (2019).","DOI":"10.1038\/s41419-019-1994-2"},{"key":"68804_CR39","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2004.06.071","volume":"44","author":"RJ Gibbons","year":"2004","unstructured":"Gibbons, R. J., Valeti, U. S., Araoz, P. A. & Jaffe, A. S. The quantification of infarct size. J. Am. Coll. Cardiol. 44, 1533\u20131542 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68804_CR40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0735-1097(01)01711-9","volume":"39","author":"RJ Burns","year":"2002","unstructured":"Burns, R. J. et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J. Am. Coll. Cardiol. 39, 30\u201336 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68804_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41401-018-0060-4","volume":"40","author":"W Fu","year":"2019","unstructured":"Fu, W., Wang, W. E. & Zeng, C. Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol. Sin. 40, 9\u201312 (2019).","journal-title":"Acta Pharmacol. Sin."},{"key":"68804_CR42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrd.2016.89","volume":"15","author":"RG Gourdie","year":"2016","unstructured":"Gourdie, R. G., Dimmeler, S. & Kohl, P. Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat. Rev. Drug Discov. 15, 620\u2013638 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68804_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.116.004387","volume":"6","author":"D Palevski","year":"2017","unstructured":"Palevski, D. et al. Loss of macrophage Wnt secretion improves remodeling and function after myocardial infarction in mice. J. Am. Heart Assoc. 6, 1\u201318 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"68804_CR44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/labinvest.2015.139","volume":"96","author":"A Uitterdijk","year":"2016","unstructured":"Uitterdijk, A. et al. UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine. Lab. Investig. 96, 168\u2013176 (2016).","journal-title":"Lab. Investig."},{"key":"68804_CR45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1503\/jpn.150131","volume":"41","author":"C Alqu\u00e9zar","year":"2016","unstructured":"Alqu\u00e9zar, C., de la Encarnaci\u00f3n, A., Moreno, F., L\u00f3pez de Munain, A. & Mart\u00edn-Requero, \u00c1. Progranulin deficiency induces overactivation of WNT5A expression via TNF-\u03b1\/NF-\u03baB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers. J. Psychiatry Neurosci. 41, 225\u2013239 (2016).","journal-title":"J. Psychiatry Neurosci."},{"key":"68804_CR46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.116.08154","volume":"69","author":"Y Fu","year":"2017","unstructured":"Fu, Y. et al. Therapeutic potential of progranulin in hyperhomocysteinemia-induced cardiorenal dysfunction. Hypertension 69, 259\u2013266 (2017).","journal-title":"Hypertension"},{"key":"68804_CR47","first-page":"8786","volume":"8","author":"S Hashmi","year":"2015","unstructured":"Hashmi, S. & Al-Salam, S. Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison. Int. J. Clin. Exp. Pathol. 8, 8786\u20138796 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"68804_CR48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan, X. et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J. Mol. Cell. Cardiol. 62, 24\u201335 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"68804_CR49","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41401-018-0197-1","volume":"40","author":"V Rusinkevich","year":"2019","unstructured":"Rusinkevich, V. et al. Temporal dynamics of immune response following prolonged myocardial ischemia\/reperfusion with and without cyclosporine A. Acta Pharmacol. Sin. 40, 1168\u20131183 (2019).","journal-title":"Acta Pharmacol. Sin."},{"key":"68804_CR50","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1152\/ajpheart.01175.2005","volume":"291","author":"S Kawano","year":"2006","unstructured":"Kawano, S. et al. Blockade of NF-\u03baB improves cardiac function and survival after myocardial infarction. Am. J. Physiol. Hear. Circ. Physiol. 291, 1337\u20131344 (2006).","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"68804_CR51","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCRESAHA.115.306919","volume":"117","author":"M Zhu","year":"2015","unstructured":"Zhu, M. et al. FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1. Circ. Res. 117, 967\u2013977 (2015).","journal-title":"Circ. Res."},{"key":"68804_CR52","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Prieto, J. et al. Neutrophil stunning by metoprolol reduces infarct size. Nat. Commun. 8, (2017).","DOI":"10.1038\/ncomms14780"},{"key":"68804_CR53","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1113\/expphysiol.2012.069831","volume":"98","author":"S Toldo","year":"2013","unstructured":"Toldo, S. et al. Interleukin-1\u03b2 blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse. Exp. Physiol. 98, 734\u2013745 (2013).","journal-title":"Exp. Physiol."},{"key":"68804_CR54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/srep21115","volume":"6","author":"JJ Mundra","year":"2016","unstructured":"Mundra, J. J., Jian, J., Bhagat, P. & Liu, C. J. Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent manner. Sci. Rep. 6, 2\u201310 (2016).","journal-title":"Sci. Rep."},{"key":"68804_CR55","doi-asserted-by":"crossref","first-page":"H2261","DOI":"10.1152\/ajpheart.01056.2010","volume":"300","author":"H Kanamori","year":"2011","unstructured":"Kanamori, H. et al. Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. AJP Hear. Circ. Physiol. 300, H2261\u2013H2271 (2011).","journal-title":"AJP Hear. Circ. Physiol."},{"key":"68804_CR56","doi-asserted-by":"crossref","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey, M. L. et al. Guidelines for experimental models of myocardial ischemia and infarction. Am. J. Physiol. Hear. Circ. Physiol. 314, H812\u2013H838 (2018).","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"68804_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-018-0696-8","volume":"113","author":"HE B\u00f8tker","year":"2018","unstructured":"B\u00f8tker, H. E. et al. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res. Cardiol. 113, 1\u201373 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"68804_CR58","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1152\/ajpheart.00707.2012","volume":"304","author":"Y Yamada","year":"2013","unstructured":"Yamada, Y. et al. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. Am. J. Physiol. Hear. Circ. Physiol. 304, 1124\u20131133 (2013).","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"68804_CR59","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.0000129770.93985.3E","volume":"109","author":"S Minatoguchi","year":"2004","unstructured":"Minatoguchi, S. et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109, 2572\u20132580 (2004).","journal-title":"Circulation"},{"key":"68804_CR60","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E Van Rooij","year":"2008","unstructured":"Van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 105, 13027\u201313032 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68804-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68804-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68804-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:56:00Z","timestamp":1670334960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68804-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68804"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68804-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"4 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11842"}}